M S Bayliss
Overview
Explore the profile of M S Bayliss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
1406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kosinski M, Bayliss M, Bjorner J, Ware Jr J, Garber W, Batenhorst A, et al.
Qual Life Res
. 2003 Dec;
12(8):963-74.
PMID: 14651415
Background: Migraine and other severe headaches can cause suffering and reduce functioning and productivity. Patients are the best source of information about such impact. Objective: To develop a new short...
2.
Bayliss M, Dewey J, Dunlap I, Batenhorst A, Cady R, Diamond M, et al.
Qual Life Res
. 2003 Dec;
12(8):953-61.
PMID: 14651414
Background: Headache impact test (HIT) is a precise, practical tool that quantifies the impact of headache on respondents' lives. It is the first widely-available dynamic health assessment (DynHA). Applications of...
3.
McHutchison J, Ware Jr J, Bayliss M, Pianko S, Albrecht J, Cort S, et al.
J Hepatol
. 2001 Feb;
34(1):140-7.
PMID: 11211891
Background/aims: Interferon plus ribavirin is the most effective therapy for chronic hepatitis C. The aim of this study was to evaluate the effect of chronic hepatitis C and therapy on...
4.
Bayliss M, Espindle D, Buchner D, Blaiss M, Ware J
Qual Life Res
. 2000 Dec;
9(4):451-66.
PMID: 11131937
Background: Asthma treatment has broadened from managing clinical markers to incorporate factors that are most meaningful to patients, collectively called health-related quality of life (HQL). Objective: To develop an asthma-specific...
5.
Graham D, Blaiss M, Bayliss M, Espindle D, Ware Jr J
Allergy Asthma Proc
. 2000 Jul;
21(3):151-8.
PMID: 10892517
The goals of asthma treatment have broadened beyond managing traditional clinical markers of disease severity, and now include a focus on benefits of treatment in terms that are most meaningful...
6.
Ware Jr J, Bayliss M, Mannocchia M, Davis G
Hepatology
. 1999 Jul;
30(2):550-5.
PMID: 10421667
Hepatitis C infects nearly 4 million Americans. Most have chronic hepatitis C (CHC), which progresses to cirrhosis in about 20% of patients. Interferon treatment leads to transient responses in about...
7.
Bayliss M
Hepatology
. 1999 Jul;
29(6 Suppl):3S-6S.
PMID: 10386074
The health care system in the United States is at a turning point. We are experiencing a shift in focus from structure and process to outcomes, and from specific clinical...
8.
Neary M, Cort S, Bayliss M, Ware Jr J
Semin Liver Dis
. 1999 Jun;
19 Suppl 1:77-85.
PMID: 10349695
Although evidence of virologic elimination, normalization of serum alanine aminotransferase levels, and reduction in liver inflammation are the principal therapeutic outcome goals in chronic hepatitis C patients, improvement in health-related...
9.
Bayliss M, Gandek B, Bungay K, Sugano D, Hsu M, Ware Jr J
Qual Life Res
. 1998 Mar;
7(1):39-55.
PMID: 9481150
A 69-item questionnaire measuring generic functioning and well-being and disease-specific health outcomes was developed and tested using the pre-treatment data from patients with chronic hepatitis C (CHC) participating in two...
10.
Keller S, Bayliss M, Ware Jr J, Hsu M, Damiano A, Goss T
Health Serv Res
. 1997 Aug;
32(3):367-84.
PMID: 9240286
Objective: To compare the measurement properties of acute (one-week recall) and standard (four-week recall) versions of SF-36 Health Survey (SF-36) scale scores. Data Sources: SF-36 data collected from 142 participants...